Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

FULCFULC
Showing 8 of 17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in FULCRUM THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.1M shares of FULC (FULCRUM THERAPEUTICS INC), worth $4M as of 2026-Q2. The position was increased (+91.4% shares). FULC represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$4M

Current Shares

1.1M

Total Value Change

+$692,775

Total Shares Change

+166,464

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+91.4%
$4M0.0%$3.66
42
2026-Q1
Increased
571,909
+76.6%
$4.4M0.0%$7.87
41
2025-Q4
Decreased
323,879
-44.8%
$3.7M0.0%$11.34
0
2025-Q3
Decreased
586,351
-48.7%
$5.4M0.0%$8.67
0
2025-Q2
Increased
1.1M
+184.0%
$7.9M0.0%$7.10
44
2025-Q1
Decreased
402,600
-25.8%
$1.2M0.0%$3.01
0
2024-Q4
Decreased
542,258
-41.6%
$2.5M0.0%$4.68
0
2024-Q3
Increased
927,961
+65.6%
$3.3M0.0%$3.77
39

Other major holders of FULC: FMR LLC, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used